X0306 4 2014-01-28 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532218 Patel Sanj K 33 HAYDEN AVE LEXINGTON MA 02421 true true false false President & CEO Common Stock 286 I Held by Abbey Road Investment Group Common Stock 2014-01-28 4 M false 6106 0.95 A 7137 D Common Stock 2014-01-28 4 M false 24832 3.52 A 31969 D Common Stock 2014-01-28 4 M false 20391 1.7 A 52360 D Common Stock 2014-01-28 4 S false 9506 87.16 D 42854 D Common Stock 2014-01-28 4 S false 32609 88.38 D 10245 D Common Stock 2014-01-28 4 S false 8402 88.95 D 1843 D Common Stock 2014-01-28 4 S false 812 90.1 D 1031 D Common Stock 2014-01-29 4 M false 50971 3.52 A 52002 D Common Stock 2014-01-29 4 S false 24817 87.19 D 27185 D Common Stock 2014-01-29 4 S false 18652 88.31 D 8533 D Common Stock 2014-01-29 4 S false 5600 89.27 D 2933 D Common Stock 2014-01-29 4 S false 1502 90.85 D 1431 D Common Stock 2014-01-29 4 S false 400 91.58 D 1031 D Stock Option (Right to Buy) 3.52 2014-01-28 4 M false 24832 0 D 2018-09-24 Common Stock 24832 55987 D Stock Option (Right to Buy) 0.95 2014-01-28 4 M false 6106 0 D 2019-12-15 Common Stock 6106 0 D Stock Option (Right to Buy) 1.7 2014-01-28 4 M false 20391 0 D 2021-05-25 Common Stock 20391 36048 D Stock Option (Right to Buy) 3.52 2014-01-29 4 M false 50971 0 D 2018-09-24 Common Stock 50971 5016 D The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on October 31, 2013. The reporting person was granted two options on 09/24/2008. These options are combined for reporting purposes herein. The first option was to purchase 99,017 Shares. 25% of such Shares vested and became exercisable on 6/23/2009, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter. The second was an option to purchase 33,005 Shares. 25% of such Shares vested and became exercisable on 9/24/2010, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter. The stock option granted the reporting person an option to purchase 117,220 Shares. 25% of such Shares vested and became exercisable on 09/25/2010, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. The stock option granted the reporting person an option to purchase 108,052 Shares. 25% of such Shares vested and became exercisable on 5/25/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $86.70 to $87.64. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.75 to $88.73. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $88.75 to $89.72. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $89.92 to $90.21. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $86.82 to $87.80. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.83 to $88.80. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $89.00 to $89.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.49 to $91.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. /s/ Christopher J. Heberlig, Attorney-in-Fact 2014-01-30